UPDATED Apr 15, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
PRN | CA$10.77 | -3.4% | -28.4% | CA$264.8m | CA$12.50 | PS26.4x | E48.1% | n/a | Healthcare | ||
HITI | CA$3.08 | -4.6% | 66.5% | CA$242.8m | CA$5.95 | PB1.8x | E134.8% | n/a | Pharmaceuticals & Biotech | ||
CPH | CA$8.91 | 5.8% | 159.8% | CA$224.7m | CA$7.62 | PE7.6x | E-12.1% | n/a | Pharmaceuticals & Biotech | ||
QIPT | CA$5.11 | -6.2% | -37.8% | CA$222.2m | CA$13.42 | PB1.4x | E54.8% | n/a | Healthcare | ||
PLTH | CA$0.90 | -10.0% | -10.0% | CA$221.4m | CA$1.96 | PS1.6x | n/a | n/a | Pharmaceuticals & Biotech | ||
AIDX | CA$1.64 | 34.4% | 628.9% | CA$215.1m | CA$1.28 | PS25.4x | E69.4% | n/a | Healthcare | ||
HTL | CA$1.35 | 2.3% | -17.7% | CA$206.2m | CA$2.33 | PS2.2x | E90.8% | n/a | Healthcare | ||
GRIN | CA$0.86 | 3.6% | 391.4% | CA$206.1m | n/a | PS6.2x | n/a | n/a | Pharmaceuticals & Biotech | ||
CRDL | CA$2.41 | -6.6% | 254.4% | CA$167.9m | CA$4.50 | PB5.8x | E53.9% | n/a | Pharmaceuticals & Biotech | ||
ZEN | CA$1.55 | 2.6% | -26.5% | CA$160.3m | n/a | PS4649.7x | n/a | n/a | Healthcare | ||
HLS | CA$4.89 | -2.0% | -19.8% | CA$157.5m | CA$6.20 | PS1.8x | E33.8% | 0% | Pharmaceuticals & Biotech | ||
NGEN | CA$2.02 | -3.3% | 17.4% | CA$145.4m | CA$5.00 | PB27.7x | n/a | n/a | Pharmaceuticals & Biotech | ||
SVA | CA$0.47 | 12.0% | -44.6% | CA$142.6m | CA$3.03 | PB36.8x | E66.5% | n/a | Pharmaceuticals & Biotech | ||
EPIC | CA$1.20 | -4.0% | -25.0% | CA$141.3m | n/a | PS3.5x | n/a | n/a | Pharmaceuticals & Biotech | ||
IAN | CA$0.02 | -20.0% | -20.0% | CA$132.3m | n/a | PE-1.2x | n/a | n/a | Pharmaceuticals & Biotech | ||
EPRX | CA$3.65 | -3.9% | -34.6% | CA$131.8m | CA$14.45 | PB42.4x | S47.9% | n/a | Pharmaceuticals & Biotech | ||
MDNA | CA$1.84 | 22.7% | 119.0% | CA$131.6m | CA$8.61 | PB6.9x | E44.8% | n/a | Pharmaceuticals & Biotech | ||
EDT | CA$0.45 | 8.5% | 48.3% | CA$128.5m | CA$1.80 | PS77.8x | S24.6% | n/a | Pharmaceuticals & Biotech | ||
FFNT | CA$0.14 | 0% | -29.3% | CA$118.8m | n/a | PE-2.1x | n/a | n/a | Pharmaceuticals & Biotech | ||
ONC | CA$1.47 | -5.2% | -2.6% | CA$110.1m | CA$5.83 | PB4x | E57.5% | n/a | Pharmaceuticals & Biotech | ||
ACOG | CA$0.72 | 0% | 193.9% | CA$104.9m | CA$1.00 | PE-5.7x | n/a | n/a | Pharmaceuticals & Biotech | ||
RX | CA$8.55 | -0.6% | 12.2% | CA$100.4m | CA$9.00 | PE15.4x | S9.9% | 2.1% | Pharmaceuticals & Biotech | ||
ACRG.A.U | US$0.50 | -3.8% | 8.7% | US$70.0m | n/a | PB2.8x | E62.8% | n/a | Pharmaceuticals & Biotech | ||
METX | CA$3.67 | 4.6% | n/a | CA$86.5m | n/a | n/a | n/a | n/a | Pharmaceuticals & Biotech |